XML 32 R26.htm IDEA: XBRL DOCUMENT

Note 18 - Major Customers	12 Months Ended
Sep. 28, 2013
Risks and Uncertainties [Abstract]
Concentration Risk Disclosure [Text Block]	18. MAJOR CUSTOMERS The largest of our medical customers are distributors who sell our products to acute care hospitals and long-term care facilities throughout the United States and Canada. One of our medical customers acquired another of our medical customers during fiscal 2013. If the customers had been under common ownership since 2011, sales to that customer would have been 13% of net sales in 2013, 11% in 2012 and 18% in 2011. We have a business relationship with another customer to distribute certain of our consumer products. Sales to this customer amounted to 32% of net sales in 2013, 34% of net sales in 2012, and 28% of net sales in 2011. See Note 19 for further information about sales to major customers.

Note 18 - Major Customers

12 Months Ended

Sep. 28, 2013

Concentration Risk Disclosure [Text Block]

18. MAJOR CUSTOMERS

The largest of our medical customers are distributors who sell our products to acute care hospitals and long-term care facilities throughout the United States and Canada. One of our medical customers acquired another of our medical customers during fiscal 2013. If the customers had been under common ownership since 2011, sales to that customer would have been 13% of net sales in 2013, 11% in 2012 and 18% in 2011.

We have a business relationship with another customer to distribute certain of our consumer products. Sales to this customer amounted to 32% of net sales in 2013, 34% of net sales in 2012, and 28% of net sales in 2011.

See Note 19 for further information about sales to major customers.

- Definition

The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date.

+ References+ Details